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Abstract Rinsing bone grafts before or both before and after
impaction might have different effects on the incorporation of
the graft. Rinsing again after impaction might negatively
influence bone induction if growth factors released by
impaction are washed away. We studied if transforming
growth factor-βs( T G F - βs) and bone morphogenetic proteins
(BMPs) are released from the mineralised matrix by
impaction and if these released growth factors induce
osteogenic differentiation in human mesenchymal stem cells
(hMSCs). Rinsed morsellised bone allografts were impacted
in a cylinder and the escaping fluid was collected. The fluid
was analysed for the presence of TGF-βs and BMPs, and the
osteoinductive capacity was tested on hMSCs. Abundant
TGF-β was present in the fluid. No BMPs could be detected.
Osteogenic differentiation of hMSCs was inhibited by the
fluid. Results from our study leave us only able to speculate
whether rinsing grafts again after impaction has a beneficial
effect on the incorporation process or not.
Résumé Laver les greffons avant et après impaction peut
avoir des conséquences diverses sur l’incorporation de la
greffe. En effet, laver à nouveau après l’impaction aura une
influence négative sur l’induction osseuse car les facteurs
de croissances relargués par l’impaction ont été éliminés.
Nous avons étudié ainsi le facteur TGF-βse tB M P s
relargués de la matrice minérale osseuse après impaction
et si ce relarguage des facteurs avaient une action
d’induction ostéogénique sur la différenciation des cellules
mésenchymateuses hMSCs. Pour cela, nous avons lavé
l’allogreffe quand celle-ci est impactée dans un cylindre et
que les fluides ont été collectés. Les fluides sont analysés
pour détecter la présence de TGF-βs et BMPSs et, les
capacités d’ostéo induction sont testées sur des cellules
mésenchymateuses humaines. Une quantité abondante de
TGF-βs se retrouve dans les fluides, par contre nous n’avons
pas retrouvé de BMPs. La différenciation ostéogénique sur
les cellules mésenchymateuses hMSCs est inhibée par ce
fluide. Les résultats de ce travail nous permettent de penser
que l’action de laver les greffons après impaction peut avoir
un effet bénéfique ou non sur l’incorporation.
Introduction
Bone impaction grafting with a cemented prostheses is a
biologically attractive technique for treating bone stock
defects around failed total hip prostheses, with long-term
clinical survival data available both on the acetabular and
the femoral sides [8, 21].
Although the technique on the acetabular side has been
well described by the original promoters [22], a dispute has
been raised about the pros and cons of rinsing the allograft
bone chips. Both rinsing once (before) and twice (before
and after) impaction are used. However, rinsing before
impaction or before and after impaction might have quite
different effects on the incorporation of the grafts.
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P.O. Box 9101, 6500 HB Nijmegen, The NetherlandsRinsing before impaction enhances the stability of graft
reconstructions by creating a higher interparticle shear
resistance [7]. Also, in more realistic acetabular testing
models with bone impaction grafting, rinsing had a positive
effect on the initial stability of the cemented cups [1, 25]. In
addition, the use of allografts induces an immunogenic
response to the graft. Since most antigenic cells are found
in the marrow, rinsing the grafts to remove blood, marrow
and fat have been shown to diminish this negative aspect
[10]. Bone grafts rinsed before impaction are better
incorporated compared to unrinsed allografts [27].
Rinsing again after impaction is performed, however,
only on the acetabular side, in the expectation of an
additional effect on the initial mechanical stability through
an increase in cement penetration. Although clinically
practised, there is no experimental data supporting the
benefit of rinsing again after impaction. It is not known
how the rinsing of morsellised bone grafts again after
impaction affects the incorporation process. Rinsing the
grafts again after impaction might have a negative effect on
bone induction if growth factors released by impaction are
washed away.
By the impaction procedure, many microfractures are
created, and biologically active factors in the bone matrix
are, consequently, released. Recently, it was shown that a
physiologically significant amount of transforming growth
factor-β (TGF-β) was released by the strong compression
of rinsed cancellous bone blocks from femoral heads [9].
Many contradictory reports have been published on the
effects of TGF-βs on bone formation [2, 12], however, the
effects of TGF-βs on bone graft incorporation are
unknown.
Furthermore, it is not known if, other, more potent
stimulators of bone induction, like bone morphogenetic
proteins (BMPs), are released in physiologically relevant
concentrations from the mineralised matrix during impac-
tion. Therefore, we studied if TGF-βs and BMPs are
released in physiologically relevant concentrations from the
mineralised bone matrix by firm impaction, and if these
released growth factors induce osteogenic differentiation in
human mesenchymal stem cells (hMSCs).
Materials and methods
Production of “impaction fluid”
Cancellous allografts were collected from five human
femoral heads obtained from the authors’ institutional bone
bank. Swabs were taken and tested for bacterial contami-
nation. All specimens were clear of bacterial contamination.
The allografts were cut to 5×5×5-mm pieces using a
rongeur and were subsequently pooled. Blood and marrow
were removed macroscopically by rinsing the grafts with
saline for approximately 1 min, leaving only a white bone
structure. Rinsing was done using a commercially available
high-pressure pulsatile lavage system (SurgiLav® Plus,
Stryker Nederland BV, Waardenburg, the Netherlands).
The grafts were in a sieve during rinsing. Allografts were
dried overnight in a laminar flow cabinet (sterile airflow) at
4°C.
The bone grafts were inserted into a cylinder with a
diameter of 30 mm. A piston, slightly smaller in diameter,
was inserted into this cylinder. A rubber ring, sealing the
piston, prevented the escape of fluid between the piston and
the wall of the cylinder. Using an MTS loading device
(MTS Systems Corporation, Minneapolis, MN, USA), the
allografts were impacted. Fluid was evacuated through a
canal in the bottom of the cylinder and were collected
sterile. The applied pressure was calculated to be
12.5 MPa. The gathered fluid was centrifuged for 10 min
at 3,000 rpm at 4°C. Any cellular and fatty debris was
separated from the supernatant. The supernatant was called
“impaction fluid.”
Analysis of “impaction fluid”
TGF-β1 and TGF-β2 levels in the “impaction fluid” were
measured by enzyme-linked immunosorbent assay (ELISA;
Quantikine®, R&D Systems Europe Ltd., Abingdon,
United Kingdom) according to the manufacturer’s instruc-
tions. The plate was read in an ELISA reader at 450 nm
(Sunrise™, Tecan Group Ltd., Männedorf, Switzerland).
Experiments were performed in triplicate.
The presence of BMPs was determined using a modified
BMP-selective reporter bioassay (BRE-luc) inducing lucif-
erase expression [16]. This assay is based on 3T3
fibroblasts stably transfected with the BRE-luc reporter
construct. In short, 3T3 BRE-luc cells were seeded in a
density of 20,000 per well in microtitre plates in D-MEM
(Gibco Invitrogen Corp., Grand Island, NY, USA) with 5%
FCS. After 24 h, BMP-containing samples were added and
the cells were incubated for a further 20 h. Luciferase
activity was quantified using the Bright-Glo™ Luciferase
Assay System (Promega, Madison, WI, USA). Lumines-
cence was measured using a plate luminometer according to
the manufacturer’s protocol (POLARstar Galaxy, BMG
Labtech GmbH, Offenburg, Germany). For the standard
curve, serial dilutions of rhBMP-2 (R&D Systems Europe
Ltd., Abingdon, United Kingdom) to final concentrations of
0 to 100 ng BMP-2/ml were used. The lower detection limit
of this assay is 1.6 ng/ml BMP-2. Experiments were
performed in triplicate.
Almost all members of the TGF-β family, including
BMPs, are secreted as latent complexes and need to be
activated to exhibit their biological activity [28]. Therefore,
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order to have an impression of latent growth factor levels.
The total growth factor levels were measured by activating
the growth factors in the samples using hydrochloric acid
and, subsequently, neutralising the samples by sodium
hydroxide, according to the manufacturer’s instructions.
Culture study
Human mesenchymal stem cells (Poietics™ hMSC, Cambrex
Bio Science Verviers, S.p.r.l., Belgium) were cultured up to
passage 7 on mesenchymal stem cell growth medium
(MSCGM™ BulletKit® (PT-3001), Cambrex Bio Science
Verviers, S.p.r.l., Belgium). The cells were incubated in a
humidified atmosphere of 92.5% air and 7.5% CO2 at 37°C.
After primary culture, cells were detached using trypsin/
EDTA (Cambrex Bio Science Verviers, S.p.r.l., Belgium),
and the cells were seeded in 96-well plates at a density of
20,000 cells/cm
2. The cells were allowed to attach overnight.
After cell attachment, the cells were cultured under static
conditions for 7 days. Cells were cultured on osteogenic
differentiation medium (hMSC Osteogenic Differentiation
BulletKit® (PT-3002), Cambrex Bio Science Verviers, S.p.r.
l., Belgium) with and without 10
−7 M dexamethasone
(Sigma, Chemical Co., St. Louis, MO, USA). The superna-
tant (“impaction fluid”) was lyophilised. Subsequently, the
lyophilised “impaction fluid” was resuspended in osteogenic
differentiation medium (without dexamethasone), equal to
the original volume of the supernatant. The hMSCs were
stimulated with 5 ng/ml TGF-β1( r h T G F - β1, R&D Systems
Europe Ltd., Abingdon, United Kingdom), 10
−8 Mv i t a m i n
D3 [1,25(OH)2D3], 100 ng/ml BMP-2 (rhBMP-2, R&D
Systems Europe Ltd., Abingdon, United Kingdom) and
10%, 20%, 40% and 80% “impaction fluid.” The culture
medium was changed every three days. Experiments were
performed in triplicate. Osteogenic differentiation medium
without dexamethasone was used as the negative control,
whereas osteogenic differentiation medium supplemented
with dexamethasone and vitamin D3 was used as the
positive control [4].
Alkaline phosphatase assay
Alkaline phosphatase (ALP) activity was measured to
obtain information about the osteogenic differentiation of
the cells. Medium was removed and the cell layers were
washed twice with phosphate buffer solution (PBS). The
cells were fixed with 4% buffered formaldehyde and
washed twice with PBS again.
The substrate solution was made by adding 1 ml of
10 mM MgCl2 to 10 ml of 1 M di-ethanol-amine (DEA)
and dissolving 52.6 mg of para-nitrophenyl phosphate
(PNPP) in 10 ml of this solution. Subsequently, 100 μlo f
substrate solution was added to each well and the plate was
incubated for 15 min. The reaction was stopped by adding
100 μl of 0.5 M NaOH. The plate was read in an ELISA
reader at 405 nm (Wallac™ VICTOR
2 1420, PerkinElmer
Life and Analytical Sciences, Inc., Boston, MA, USA).
Neutral red assay
A neutral red (NR) assay was performed to obtain an
indication of the number of viable cells (proliferation). A
1:1 solution of neutral red stock (1 mg/ml milliQ water) and
1.8% NaCl solution was made and filtered. One hundred
microlitres (100 μl) of this solution was added to each well
and the plate was incubated for 90 min at 37°C. Neutral red
solution was removed and the cell layers were washed
twice with PBS. Subsequently, 100 μl of elution buffer
(0.05 M NaH2PO4/50% EtOH) was added to each well. The
plate was read in an ELISA reader at 550 nm (Wallac™
VICTOR
2 1420, PerkinElmer Life and Analytical Sciences
Inc., Boston, MA, USA). The neutral red assay was used to
correct the alkaline phosphatase assay for the number of
viable cells.
Results
Analysis of “impaction fluid”
Analysis of the “impaction fluid” revealed that TGF-β was
abundant. Both TGF-β1a n dT G F - β2 were present in the
“impaction fluid” in physiologically significant amounts. The
total levels of TGF-β1a n dT G F - β2 present after activation
were 5.39 (±1.12) ng/g bone and 1.20 (±0.12) ng/g bone,
respectively. Before the samples were activated, an already
active amount of 0.43 (±0.05) ng TGF-β1/g bone and 0.13
(±0.11) ng TGF-β2/g bone was measured (Fig. 1). No BMPs
could be detected using the BMP-selective reporter bioassay.
Luciferase expression did not exceed the detection limit of
1.6 ng BMP-2/ml.
Cell culture study
Adding dexamethasone to the osteogenic differentiation
medium caused an approximately three-fold increase in
ALP activity. Vitamin D3 added to osteogenic differentia-
tion medium supplemented with dexamethasone showed
the highest induction of ALP activity, whereas the addition
of 5 ng/ml TGF-β1 strongly suppressed the induction of
ALP activity. The “impaction fluid” dose-dependently
suppressed the ALP activity induced by dexamethasone
(Fig. 2). Both 40% and 80% “impaction fluid” showed
similar suppression to 5 ng/ml TGF-β1.
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The fracture surface created by impaction could have a
growth-promoting effect by enabling the release of growth
factors. Rinsing morsellised bone grafts again after impac-
tion, therefore, might have a negative effect on bone
induction if growth factors released during impaction are
washed out. In our study, we examined if TGF-β and
B M P sa r er e l e a s e df r o mt h em i n e r a l i s e dm a t r i xb y
impaction, and whether these released growth factors
induce osteogenic differentiation in hMSCs.
Both TGF-β1 and TGF-β2 were abundantly present in
“impaction fluid.” Corresponding to what is seen in
demineralised bone, in our study, most TGF-β was present
in a latent form. Bone grafts from five femoral heads were
pooled to minimise variation to overcome possible bias.
However, it should be noticed that a large variation of TGF-
β exists in human bone tissue both in tissue location and
between individuals [19]. Our results are in accordance
with the results of Fyhrie et al. [9] who recently showed
that strong mechanical compression of cancellous bone
blocks from femoral heads accelerates the release of TGF-
β2. In addition, they and others suggested that mechanical
loading also might accelerate the release of other growth
factors, like BMPs, from mineralised bone matrix [3, 9]. In
our study, however, no BMPs could be detected. In the light
of the overwhelming literature on BMPs in bone [23, 24],
we have to conclude from this experiment that BMPs
cannot be released from the mineralised matrix by
impaction. The BMPs in bone are considered to be
activated by demineralisation [26]; however, as described
in Burwell’s classical work on bone grafting, some new
bone formation may be induced also from non-demineral-
ised allografts [5]. If all BMPs are retained in the bone, this
might explain the coupling of resorption and new bone
formation during the incorporation of morsellised cancel-
lous bone in bone impaction grafting [20].
Since TGF-β is abundantly present in the “impaction
fluid,” it is not surprising to see a suppression of osteogenic
differentiation with an increasing concentration of “impac-
tion fluid” in our culture experiment. TGF-β is known to
inhibit the ALP expression of mesenchymal stem cells
(MSCs), even when these cells are stimulated with BMPs
[12, 17]. In contrast to BMPs, TGF-β is unable to induce
osteogenesis in mesenchymal pluripotent cells [12, 14].
From this perspective, it seems that rinsing bone grafts
again after impaction might even be beneficial if TGF-β is
washed away.
Data from numerous in vitro experiments have demon-
strated the role of TGF-β in every stage of bone formation [6,
12]. Despite conflicting results, most data support the
following model [12]: TGF-β increases bone formation in
vitro mainly by recruiting osteoblast progenitors and
stimulating their proliferation, thus, expanding the pool of
committed osteoblasts, in addition to promoting the early
stages of differentiation (bone matrix production). On the
Fig. 2 Data from cell culture.
Human mesenchymal stem cells
(hMSCs) were cultured with and
without dexamethasone. As a
measure for osteogenic differ-
entiation, alkaline phosphatase
activity (ALP) was corrected for
the number of viable cells (NR).
Data are mean±SD of experi-
ments performed in triplicate
Fig. 1 Level of transforming growth factor-β1 and -β2 (TGF-β1 and
TGF-β2) measured in the “impaction fluid.” Both total and already
active growth factor levels are shown. Data are mean±standard
deviation (SD) of experiments performed in triplo
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mineralisation. These later stages are regulated by other
growth factors, like BMPs. In other words, TGF-β generally
inhibits the mineralisation of the matrix it helps to produce.
However, TGF-β not only modulates bone formation, but
it can also stimulate osteoclast recruitment, formation and
function [11, 15]. Bone resorption is more detrimental for the
outcome of impaction grafting than just suppression or lack
of bone formation, because resorption may compromise
implant fixation [13, 18]. In addition, little or no BMPs from
bone can be released prior to demineralisation. Only
biological remodelling might free these factors (BMPs) to
stimulate bone formation. Therefore, removing the excess of
TGF-β from bone grafts might be a useful procedure.
On the contrary, TGF-β released after impaction might,
indeed, be beneficial at an early stage postoperatively when
chemotactic and proliferative signals might be needed.
Furthermore, TGF-β promotes the early stages of osteoblast
differentiation. However, the fluid released by the impac-
tion procedure in clinical surgery will, probably, only be in
situ for a short period of time at the very early postoperative
stage, when osteoblast differentiation is not relevant.
It should be noticed that results obtained in vitro are often
not in line or even contradictory to in vivo observations. In
vivo, the presence of other growth factors, cytokines and
hormones in the bone environment and the environment
itself determine the exact outcome of TGF-β function.
In summary, by rinsing morsellised bone grafts again
after impaction, growth factors (TGF-βs) released during
impaction are washed out. Although TGF-β appears to be
a potent stimulator of chemotaxis and the proliferation of
osteoblasts, but also of osteoclast recruitment, formation
and bone resorption, more potent stimulators of bone
formation (BMPs) are not released from a mineralised
matrix during impaction. To our knowledge, there is only
o n es t u d yr e p o r t i n gi nv i v od a t ao nt h ee f f e c t so fr i n s i n g
and the impaction of morsellised bone grafts on bone
ingrowth [27]. Rinsing before impaction increased bone
ingrowth in the allograft group to approach that of
autografts. However, rinsing after impaction did not
additionally alter bone ingrowth. The results from our
study, and the dual effects of TGF-β reported in the
literature, leave us only able to speculate whether rinsing
grafts again after impaction has a beneficial effect on the
incorporation process.
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